Form 4 for IDXX Idexx Laboratories
Accepted 2023-02-10 00:00:00 ET · period of report 2023-02-08 · accession 0001567619-23-002390 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-10 | 2023-02-09 | IDXX | Hunt Nimrata | EVP | M - OptEx | $141.60 | +706 | 10.5K | +7% | +$100.0K |
| DM | 2023-02-10 | 2023-02-08 | IDXX | Hunt Nimrata | EVP | A - Grant | — | +8,406 | 5,868 | New | — |
| D | 2023-02-10 | 2023-02-09 | IDXX | Hunt Nimrata | EVP | M - OptEx | — | -706 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | M | A | 706 | $141.60 | 10,463.28 | D | — | — | (F1) Includes a total of 55 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022. |
| 2 | Derivative | Restricted Stock Unit | 2023-02-08 | A | A | 1,508 | — | 3,531 | D | — · — to — | 1,508 Common Stock | (F7) Not applicable. (F4) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in one installment on February 14, 2026. |
| 3 | Derivative | Incentive Stock Option (right-to-buy) | 2023-02-08 | A | A | 201 | — | 201 | D | $497.43 · — to 2033-02-07 | 201 Common Stock | (F7) Not applicable. (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2027. |
| 4 | Derivative | Restricted Stock Unit | 2023-02-08 | A | A | 829 | — | 4,360 | D | — · — to — | 829 Common Stock | (F7) Not applicable. (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. |
| 5 | Derivative | Incentive Stock Option (right-to-buy) | 2023-02-09 | M | D | 706 | — | 0 | D | $141.60 · — to 2027-02-13 | 706 Common Stock | (F7) Not applicable. (F6) Grant of option to buy 1,043 shares of Issuer common stock that vested as to 337 shares on February 14, 2021 and tthe remainder on February 14, 2022. |
| 6 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2023-02-08 | A | A | 5,868 | — | 5,868 | D | $497.43 · — to 2033-02-07 | 5,868 Common Stock | (F7) Not applicable. (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2024. |